DYN•benzinga•
Jefferies Maintains Buy on Dyne Therapeutics, Raises Price Target to $42
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 20, 2024 by benzinga